Article Text

other Versions

PDF
Extended report
Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis
  1. Anne P Liao1,
  2. Mohammad Salajegheh1,
  3. Remedios Nazareno1,
  4. Jonathan C Kagan2,
  5. Ronald G Jubin3,
  6. Steven A Greenberg1
  1. 1Department of Neurology, Division of Neuromuscular Disease, Brigham and Women's Hospital and Children's Hospital Informatics Program, Harvard Medical School, Boston, Massachusetts, USA
  2. 2Department of Gastroenterology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA
  3. 3PBL InterferonSource, Piscataway, New Jersey, USA
  1. Correspondence to Dr Steven A Greenberg, Department of Neurology, Division of Neuromuscular Disease, Brigham and Women's Hospital and Children's Hospital Informatics Program, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA; sagreenberg{at}partners.org

Abstract

Objectives To determine whether type 1 interferon (IFN) proteins in blood are associated with downstream type 1 IFN-inducible gene expression in blood from patients with myositis.

Methods IFNα, IFNβ and IFNω concentrations were measured by ELISA in 129 blood samples (from 93 patients with dermatomyositis (DM), inclusion body myositis, polymyositis and other muscle diseases and from 36 healthy volunteers). Their concentrations were correlated with their ability to stimulate type 1 IFN-inducible gene transcription in a functional assay for 123 of these samples and the type 1 IFN-inducible blood gene expression from 70 of the same samples.

Results Blood IFNβ concentration was uniquely associated with DM (p=0.0004), detectable in 64% of samples from patients with untreated or minimally treated DM and 35% of all DM samples compared with 6% of other inflammatory myopathy and 6% of healthy volunteer samples. Blood IFNβ, but not IFNα or IFNω, correlated with high blood type 1 IFN-inducible gene expression (p=0.01). Healthy volunteer samples with a high ELISA signal for IFNα and IFNω lacked functional bioassay activity and such a signal was confirmed as artefactual.

Conclusion Elevated blood IFNβ protein concentration is associated with DM. Systemic and local production of IFNβ might contribute to, but may not fully explain, the marked overproduction of type 1 IFN-inducible transcripts and proteins seen in DM muscle and blood.

Statistics from Altmetric.com

Footnotes

  • Funding Funded through Brigham and Women's Hospital neurology departmental funds and philanthropic contributions.

  • Competing interests Dr Jubin's employer manufactures an assay for the detection of interferon β.

  • Ethics approval  This study was conducted with the approval of the Brigham and Women's Hospital and Children's Hospital Boston.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.